However, which breast cancer cell-derived metabolites bind to MR1 for MAIT cell activation and whether this selective recognition can be leveraged for therapeutic intervention or if it predominantly contributes to tumor immune evasion remain open questions, necessitating further exploration into the functional dynamics of MAIT cells in breast cancer. The gene discussed is MR1; the disease is breast carcinoma.